Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2000
06/15/2000WO2000034304A1 Eosinophil-specific expression of transgenes
06/15/2000WO2000034303A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
06/15/2000WO2000034302A1 Antisense modulation of egr-1 expression
06/15/2000WO2000034301A1 Antisense modulation of g-alpha-11 expression
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000033889A1 Antisense modulation of g-alpha-13 expression
06/15/2000WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen
06/15/2000WO2000033870A2 New cancer treatments
06/15/2000WO2000033655A1 Plastin promoter directed gene therapy
06/15/2000WO2000023618A8 Polymorphism in a tgf-beta gene correlated to osteoporosis
06/15/2000WO2000015649A9 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
06/15/2000WO2000014234A9 Prostate specific promoter and regulation of gene expression
06/15/2000WO2000012678A3 Staphylococcus aureus genes and polypeptides
06/15/2000WO2000011151A3 Direct oviduct transgenesis
06/15/2000WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
06/15/2000WO2000009705A3 Selection method
06/15/2000WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
06/15/2000WO2000008192A3 Herpesviral vectors for gene delivery
06/15/2000WO2000008178A3 Murine dna molecules encoding polypeptides having kinase functions
06/15/2000WO2000008143A3 Gene isolated on the short arm of human chromosome 17
06/15/2000WO2000006749A3 Sulfur metabolism enzymes
06/15/2000WO2000006732A9 Polynucleotide encoding an autoantigen associated with endometriosis
06/15/2000WO2000006726A3 Delta-related polypeptides
06/15/2000WO2000006718A3 Expression of functional eukaryotic proteins
06/15/2000WO2000005378A3 Streptococcus suis vaccines and diagnostic tests
06/15/2000WO2000005374A3 Molecules associated with cell proliferation
06/15/2000WO2000005369A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
06/15/2000WO2000005366A3 Xiap ires and uses thereof
06/15/2000WO2000005253A3 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
06/15/2000WO2000004154A3 Genes encoding sulfate assimilation proteins
06/15/2000WO2000003018A3 Antibiotic protein and method of production
06/15/2000WO2000003011A3 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5
06/15/2000WO2000001846A3 Characterisation of gene function using double stranded rna inhibition
06/15/2000WO2000001821A3 Neurotransmission associated proteins
06/15/2000WO2000000619A3 MATERIALS AND METHODS FOR THE ALTERATION OF ENZYME AND ACETYL CoA LEVELS IN PLANTS
06/15/2000WO1999067386A3 Differentially expressed genes in pancreatic cancer and displasia
06/15/2000WO1999066051A3 Nek-related and bub1-related protein kinases
06/15/2000WO1999064614A3 Polyunsaturated fatty acids in plants
06/15/2000WO1999064592A3 Green fluorescent proteins for measuring the ph of a biological sample
06/15/2000WO1999063054A3 Mutant forms of the al2 gene of geminiviruses
06/15/2000WO1999061452A3 acpS
06/15/2000WO1999061052A9 Oral immunization with papillomavirus virus-like particles
06/15/2000WO1999060140A3 Geminivirus inducible promoter sequences and the uses thereof
06/15/2000WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
06/15/2000WO1999059562A9 Method of treating or preventing abnormal cardiac cell growth by inhibiting the 12-lipoxygenase pathway
06/15/2000WO1999058098A3 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
06/15/2000WO1999055858A3 Human nucleic acid sequences obtained from pancreas tumor tissue
06/15/2000WO1999055847A3 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus
06/15/2000WO1999047669A3 Human nucleic acid sequences from tissue of breast tumors
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000WO1999002550A8 Ctl epitopes from ebv
06/15/2000DE19903371C1 A mammal with inducible in situ ductal carcinoma useful as a model for research and identification of therapeutics
06/15/2000DE19857654A1 Beeinflussung des Blühverhaltens von Pflanzen durch Expression Saccharose-spaltender Proteine Influencing the flowering behavior of plants by expression of sucrose-cleaving proteins
06/15/2000DE19856066A1 A novel metabotropic receptor complex from the central nervous system, related coding sequences and methods of identifying binding substances, ligands and interactions with other proteins
06/15/2000DE19856065A1 Rekombinanter, adenoviraler Vektor mit limitierter Autoreplikationsfähigkeit in vivo A recombinant adenoviral vector with limited car capacity for replication in vivo
06/15/2000DE19844931C1 Verfahren zur DNS- oder RNS-Sequenzierung A method for DNA or RNA sequencing
06/15/2000CA2791961A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/15/2000CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000CA2354986A1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro
06/15/2000CA2354673A1 Method for determining asthma susceptibility
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2354610A1 Human secretory phospholipase a2
06/15/2000CA2354322A1 Methods of identifying point mutations in a genome
06/15/2000CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2354190A1 Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
06/15/2000CA2354188A1 Cancer cell vaccine
06/15/2000CA2354150A1 Detection of rantes gene promotor polymorphisms
06/15/2000CA2354073A1 Activated cation channel of the osteoblast as a mechanism of bone anabolism
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2354028A1 Neisseria meningitidis basb041 polypeptides and encoding polynucleotides and uses thereof
06/15/2000CA2354026A1 Beta-1,3-galactosyltransferase homologs
06/15/2000CA2353797A1 Neuron-associated proteins
06/15/2000CA2353773A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000CA2353616A1 Assays for compounds which increase phospholipase a2 activity
06/15/2000CA2353596A1 Method for the immobilization of oligonucleotides
06/15/2000CA2353559A1 Facs assisted methods for introducing individual chromosomes into cells
06/15/2000CA2353525A1 Drug targets in candida albicans
06/15/2000CA2353522A1 Treatment of pompe's disease
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/15/2000CA2352534A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000CA2352476A1 Array and method for analysing nucleic acid sequences
06/15/2000CA2352472A1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
06/15/2000CA2352046A1 Glucoamylases with n-terminal extensions
06/15/2000CA2351890A1 Method and composition for preserving viruses
06/15/2000CA2351641A1 Plastin promoter directed gene therapy
06/15/2000CA2351628A1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
06/15/2000CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3
06/15/2000CA2351346A1 Protein scaffolds for antibody mimics and other binding proteins
06/15/2000CA2349404A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/15/2000CA2342967A1 Modifying protein immunogenicity
06/14/2000EP1008653A2 Recombinant adenoviral vector with limited capability to self-replicate
06/14/2000EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
06/14/2000EP1008651A2 Modified DNA sequence coding for hexose oxidase and use hereof
06/14/2000EP1008650A1 Novel mapk kinase
06/14/2000EP1008649A2 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-b2(TGF-b2)
06/14/2000EP1008352A1 Brain-protective agent
06/14/2000EP1008351A1 Carcinostatic agents
06/14/2000EP1007969A1 Lithographic mask design and synthesis of diverse probes on a substrate
1 ... 3229 3230 3231 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3244 3245 3246 3247 3248 3249 ... 4023